Related Experiment Videos
Tick-borne encephalitis and its prevention in Hungary
Medicinski Pregled
|October 14, 1998
Summary
Tick-borne encephalitis (TBE) cases in Hungary show a slight decrease, primarily affecting males aged 30-39. TBE vaccination and post-exposure prophylaxis with gamma-globulins are effective. An international vaccine standard is needed.
Area of Science:
- Epidemiology
- Infectious Diseases
- Vaccinology
Background:
- Tick-borne encephalitis (TBE) has been a registered disease in Hungary since 1977.
- Recent years show a moderate decrease in TBE incidence.
- TBE predominantly affects males in the 30-39 age group.
Purpose of the Study:
- To analyze the epidemiological trends of TBE in Hungary.
- To evaluate the effectiveness of TBE vaccination and post-exposure prophylaxis.
- To discuss the necessity of an international standard for TBE vaccines.
Main Methods:
- Analysis of registered TBE cases in Hungary.
- Review of data on TBE vaccination efficacy.
- Assessment of hyperimmune gamma-globulin effectiveness for prophylaxis.
Main Results:
- A moderate decrease in TBE cases observed in the last four years.
- Males are twice as likely to be affected compared to females.
- TBE vaccination efficacy is confirmed by field trials.
- Specific hyperimmune gamma-globulins are effective for post-exposure prophylaxis.
Conclusions:
- TBE remains a significant public health concern in Hungary.
- Vaccination and prompt post-exposure prophylaxis are crucial for TBE management.
- Establishing an international standard for TBE vaccines is recommended to ensure quality and efficacy.